1. Syneron Medical Ltd. Company Overview
Thomas Goslau
Director of Marketing and Sales, Asia-Pacific

2. Syneron Medical Ltd. - Profile
선두주자가 되기 위한 비전을 가진 Israeli high tech회사로서 2000년
8월에 설립되었다.
미용의료 시장에서 테크놀로지의 다음 세대인 elòs (electro-optical synergy)는 독자적인 테크놀로지로 특허를 받았으며 독점적으로 성장해 오고 있다.
Syneron은 북미, 유럽, 아시아 태평양 그리고 남미에 marketing, sales 그리고 service network를 설립했다.
북미의 Syneron Inc와 유럽의 Syneron GmbH는 marketing과 sales의 Syneron이 소유하고 있는 자회사들이다.
Syneron Medical (HK) Ltd 2004년 5월에 오픈했다.

3. Electro-optical Synergy
elòs ™
Electro-optical Synergy
Optical (light and laser)
Conducted RF
Cooling and other energy sources

4. The elòs Product Family (current)

5. Aurora DS/SR/AC/… RF Cooling DS – Hair Removal SR – Skin Renewal
elòs Energy Synergy
Pulsed Light RF
Cooling
Applications
DS – Hair Removal
SR – Skin Renewal
AC – Acne
Specification
DS nm
SR nm
AC nm

6. Polaris Diode Laser RF Cooling LV – Leg Vein and Vascular 900-915nm
elòs Energy Synergy
Diode Laser RF
Cooling
Applications
WR – Wrinkle Reduction
LV – Leg Vein and Vascular
Specifications nm

7. Shaper (VelaSmooth) Tissue Mobilization Light RF IR light up to 20W
elòs Energy Synergy
Pulsed Vacuum Suction
Tissue Mobilization
Light RF
Applications
CL – Cellulite Reduction
Specifications
Conducted RF up to 20W
IR light up to 20W

8. 제품 판매 현황 법적 승인 Aurora: FDA and CE Mark Polaris: FDA and CE Mark
1200 Aurora systems worldwide (2004,3월):
북미 720
유럽 250
아시아 태평양 230
Polaris WR: 2003년 9월 이래로 아시아에만 65대의 Polaris가 설치되었다.

9. Medical Advisory Board
Neil Sadick, M.D. – Chairman
Tina Alster, M.D.
Patrick Bitter, M.D.
Christine Dierickx, M.D.
Jerome Garden, M.D.
David Goldberg, M.D.
Suzanne Kilmer, M.D.
Stanley Kovak, M.D.
Michael Kulick, M.D.
Stephen Mulholland, M.D.
Thomas Rohrer, M.D.
Kawashima, M.D.
Rod Rohrich, M.D.

10. New Applications Development
During 2004, Syneron plans on developing:
Comet™ – Diode laser based hair removal
Fat reduction platform based on revolutionary technology
The 2005 Family of Applications:
DS – Hair removal
SR – Superficial Vascular and Pigmented
WR – Wrinkles and Texture
LV – All visible blood vessels
AC – Acne
PV – Psoriasis, vetiligo
CL – Cellulite
DF – Deep Fat

11. Moving Forward
To establish world-wide recognition as leader in the aesthetic medical market.
To double sales to a level of $ 70 M annually.
To strengthen sales and marketing network through expansion of the marketing, sales and service infrastructure in Asia-Pacific and South America

12. elòs Our Commitment to Customers
excellence in technology
leadership in the market
ōpportunities for our customers
service for our customers